BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/15/2026 3:59:54 AM | Browse: 4 | Download: 0
| Category |
Pediatrics |
| Manuscript Type |
Retrospective Study |
| Article Title |
Sirolimus for the treatment of vascular tumors and malformations in children: A 10-year single-institution retrospective study
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nattaporn Thongngam, Lalita Sathitsamitphong, Wipawee Morakote, Supapitch Chanthong, Supawadee Maneekesorn, Rungrote Natesirinilkul, Pimlak Charoenkwan and Chane Choed-Amphai |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chane Choed-Amphai, Assistant Professor, MD, PhD, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, No. 110 Intawarorot Road, Sriphum, Muang, Chiang Mai 50200, Thailand. chane.c@cmu.ac.th |
| Key Words |
Sirolimus; Vascular anomalies; Vascular malformations; Vascular tumors; Children |
| Core Tip |
Sirolimus is increasingly used as targeted therapy for pediatric vascular anomalies, yet real-world clinical data remain limited. In this retrospective study of children with vascular tumors and malformations, sirolimus demonstrated a high response rate and an acceptable safety profile across diverse disease subtypes. Rapid resolution of Kasabach-Merritt phenomenon was observed in patients with kaposiform hemangioendothelioma receiving combination therapy. However, disease progression occurred after treatment discontinuation, highlighting the need for careful post-therapy monitoring. These findings support sirolimus as an effective treatment option in refractory or unresectable pediatric vascular anomalies and emphasize the importance of optimizing treatment duration and follow-up strategies. |
| Citation |
Thongngam N, Sathitsamitphong L, Morakote W, Chanthong S, Maneekesorn S, Natesirinilkul R, Charoenkwan P, Choed-Amphai C. Sirolimus for the treatment of vascular tumors and malformations in children: A 10-year single-institution retrospective study. World J Clin Pediatr 2026; In press |
 |
Received |
|
2026-01-30 00:28 |
 |
Peer-Review Started |
|
2026-01-30 00:31 |
 |
First Decision by Editorial Office Director |
|
2026-02-12 08:24 |
 |
Return for Revision |
|
2026-02-12 08:24 |
 |
Revised |
|
2026-03-13 01:37 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-04-15 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-15 03:59 |
 |
Articles in Press |
|
2026-04-15 03:59 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345